The Risks of Turning Races Into Genes
By Matthew W. Hughey,
The Huffington Post
| 08. 20. 2015
Untitled Document
From 22-25 August, sociologists from around the nation and world will descend upon the Windy City of Chicago to discuss sundry issues as they participate in the annual meeting of the American Sociological Association. One issue, however, is quite controversial: do genes or the social environment determine our behavior and health? Precisely, does nature or nurture determine the outcome of racial differences and racial inequality found throughout society?
Many readily acknowledge scientific advances are a necessary part of an improving society. From making cars more efficient on the road and beaming pictures from Pluto across the solar system to Earth, to developing new medical procedures to help us live better and making a longer lasting light bulb. Despite the many improvements science affords, cultural bias and normative assumptions can undergird the scientific methods and lead us down a dangerous path that has plagued American society for centuries. This path relies on a logic about race and difference that was and continues to be shared by many: from Thomas Jefferson to Dylan Roof, the white supremacist who murdered...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...